Pharmaceutical Research

With fall vaccination season rapidly approaching, a team of Canadian healthcare professionals has released an extensive guideline on reducing the needle-related pain and fear that both children and adults can experience.

‘This is often a disease of young adults and this scarring lasts for the rest of their lives.’

A randomized trial compared periurethral and intravaginal application techniques in postmenopausal women with recurrent urinary tract infections.

Randomized clinical trial examines whether single-dose intrauterine instillation of mepivacaine reduces pain during intrauterine device placement compared to placebo.

A Vancouver study put Cascade-Watch to the test, revealing both the potential and limitations of using medication data to identify prescribing cascades.

At the Canadian Dermatology Association's annual conference in Calgary, Dr. Mark Kirchhof discussed research on cannabis and its potential to treat skin conditions such as psoriasis.

Two-phase study compares the risk of hyponatremia associated with individual second-generation antipsychotics.

U.S. researchers evaluate clinical response, safety and time to improvement with high-dose oral vitamin D for toxic erythema of chemotherapy and acute radiation dermatitis.

A study from Swedish researchers has found that reversing nivolumab and ipilimumab dose amounts improved survival rates, while reducing treatment-related toxicity.